These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21034421)

  • 1. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.
    Taratula O; Garbuzenko O; Savla R; Wang YA; He H; Minko T
    Curr Drug Deliv; 2011 Jan; 8(1):59-69. PubMed ID: 21034421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.
    Taratula O; Garbuzenko OB; Kirkpatrick P; Pandya I; Savla R; Pozharov VP; He H; Minko T
    J Control Release; 2009 Dec; 140(3):284-93. PubMed ID: 19567257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.
    Shah V; Taratula O; Garbuzenko OB; Taratula OR; Rodriguez-Rodriguez L; Minko T
    Clin Cancer Res; 2013 Nov; 19(22):6193-204. PubMed ID: 24036854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
    Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
    Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.
    Patil ML; Zhang M; Taratula O; Garbuzenko OB; He H; Minko T
    Biomacromolecules; 2009 Feb; 10(2):258-66. PubMed ID: 19159248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LHRH-targeted nanoparticles for cancer therapeutics.
    Minko T; Patil ML; Zhang M; Khandare JJ; Saad M; Chandna P; Taratula O
    Methods Mol Biol; 2010; 624():281-94. PubMed ID: 20217603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimer-nanoparticle conjugates in nanomedicine.
    Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
    Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
    Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
    Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.
    Khodadust R; Unsoy G; Gunduz U
    Biomed Pharmacother; 2014 Oct; 68(8):979-87. PubMed ID: 25458787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance.
    Pan J; Mendes LP; Yao M; Filipczak N; Garai S; Thakur GA; Sarisozen C; Torchilin VP
    Eur J Pharm Biopharm; 2019 Mar; 136():18-28. PubMed ID: 30633973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer.
    Schumann C; Chan S; Khalimonchuk O; Khal S; Moskal V; Shah V; Alani AW; Taratula O; Taratula O
    Mol Pharm; 2016 Jun; 13(6):2070-83. PubMed ID: 27170529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies and advances in nanomedicine for targeted siRNA delivery.
    Nimesh S; Gupta N; Chandra R
    Nanomedicine (Lond); 2011 Jun; 6(4):729-46. PubMed ID: 21718181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment.
    Ahmed R; Amreddy N; Babu A; Munshi A; Ramesh R
    Methods Mol Biol; 2019; 1974():265-290. PubMed ID: 31099010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70
    Ma J; Kala S; Yung S; Chan TM; Cao Y; Jiang Y; Liu X; Giorgio S; Peng L; Wong AST
    Mol Ther; 2018 Jan; 26(1):70-83. PubMed ID: 29241971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells.
    Guthi JS; Yang SG; Huang G; Li S; Khemtong C; Kessinger CW; Peyton M; Minna JD; Brown KC; Gao J
    Mol Pharm; 2010 Feb; 7(1):32-40. PubMed ID: 19708690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.